Researchers have found in a new cohort study that the use of statins in patients with chronic liver disease was associated ...

The primary outcome was the cumulative incidence of hepatocellular carcinoma and hepatic decompensation. At 10 years follow-up, statin users showed a significantly reduced incidence of ...

Researchers found that statin use decreased the risk for hepatocellular carcinoma and hepatic decompensation, which is an advanced stage of liver disease. The authors found that statin use appeare ...

WEDNESDAY, March 19, 2025 (HealthDay News) -- For patients with chronic liver disease, statin use is associated with a ...

LIVER CANCER, the third leading cause of cancer-related deaths globally, is primarily attributed to hepatocellular carcinoma ...

Cumulative Incidence of Hepatocellular Carcinoma (HCC) and Hepatic Decompensation Among Statin Users and Nonusers. Credit: ...

A new study reveals how a critical imbalance in bile acids—the substances made by the liver that help digest fats—can trigger ...

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

Hepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.